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ABSTRACT The determinants of relaxation in cardiac muscle are poorly understood, yet compromised relaxation ac-
companies various pathologies and impaired pump function. In this study, we develop a model of active contraction to elucidate
the relative importance of the [Ca21]i transient magnitude, the unbinding of Ca
21 from troponin C (TnC), and the length-
dependence of tension and Ca21 sensitivity on relaxation. Using the framework proposed by one of our researchers, we ex-
tensively reviewed experimental literature, to quantitatively characterize the binding of Ca21 to TnC, the kinetics of tropomyosin,
the availability of binding sites, and the kinetics of crossbridge binding after perturbations in sarcomere length. Model param-
eters were determined from multiple experimental results and modalities (skinned and intact preparations) and model results
were validated against data from length step, caged Ca21, isometric twitches, and the half-time to relaxation with increasing
sarcomere length experiments. A factorial analysis found that the [Ca21]i transient and the unbinding of Ca
21 from TnC were the
primary determinants of relaxation, with a ﬁvefold greater effect than that of length-dependent maximum tension and twice the
effect of tension-dependent binding of Ca21 to TnC and length-dependent Ca21 sensitivity. The affects of the [Ca21]i transient
and the unbinding rate of Ca21 from TnC were tightly coupled with the effect of increasing either factor, depending on the ref-
erence [Ca21]i transient and unbinding rate.
INTRODUCTION
With each beat, the heart pumps blood around the body. The
cyclical activation and relaxation of tension that takes place
occurs at the sarcomere spatial scale and is controlled by
cellular mechanisms. Each sarcomere is made up of interdig-
itated protein ﬁlaments of actin and myosin. Crossbridges pro-
truding from myosin bind to actin, whereupon they undergo
a conformational change, causing the bound crossbridges to
pull each ﬁlament in opposite directions, producing tension.
The process is controlled by both the local free Ca21 and the
intrinsic properties of the sarcomeres themselves.
Contraction is initiated by an increase in local [Ca21]i.
Ca21 binds to troponin C (TnC) and the resulting shift of
tropomyosin reveals the actin binding sites, allowing cross-
bridges to bind and generate tension. After the removal of
[Ca21]i, bound Ca
21 unbinds from TnC, tropomyosin blocks
the actin binding sites, crossbridges detach, and tension
returns to zero. The above processes producing the initiation
of contraction in cardiac muscle are extensively quantiﬁed;
however, the equally important mechanisms governing relax-
ation after contraction are poorly characterized. Thus although
the steps are known in the process of relaxation, what controls
each step and which step is the most important is unknown.
Relaxation is often quantiﬁed by the half-time to relax-
ation (RT50 the time for tension to decay by 50% from the
peak value). RT50 is determined by both the [Ca
21]i transient
and the intrinsic properties of the myoﬁlaments. The [Ca21]i
transient inﬂuences RT50 when altered pharmacologically
(1,2) or by increasing the stimulation frequency (3). The
myoﬁlament properties implicated as determinants of RT50
include the tension-dependent binding of Ca21 to TnC (4),
inhomogeneous sarcomere shortening (5), crossbridges inhib-
iting tropomyosin returning to its resting state (4), phosphor-
ylation of troponin I (6), and sarcomere length (SL) (7).
Unraveling the relative inﬂuences of each mechanism has
proven challenging experimentally. In this study, we address
this issue by unifying experimental data into a mathematical
model to analyze the signiﬁcant factors determining relax-
ation.
Building on the successful approach of cardiac electro-
physiology models, cardiac contraction models are now
beginning to quantify numerous phenomena, which have pre-
viously been poorly deﬁned or only understood and charac-
terized in isolation. Models of cardiac contraction have
quantiﬁed cooperative mechanisms (8), the effects of con-
traction in the forward problem of electrocardiography (9),
and ventricular pacing on contraction (10), for example.How-
ever, the parameters used in active contraction models are
often derived from limited sets of experimental results. Here,
each parameter was rationalized from numerous sources, and
where possible, multiple experimental modalities, through an
extensive review of the literature. The sources of each param-
eter and a brief description of the experimental conditions
under which it was obtained are provided in the Tables.
The model is depicted in Fig. 1 and was based on the
framework proposed by Hunter et al. (11). The equations and
the parameters are described in the following stages:
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1. The kinetics of Ca21 binding to TnC in the absence, and
then presence, of tension was deﬁned using steady-state
and transient experimental data.
2. The shift in tropomyosin (Tm) to reveal the actin binding
sites resulting from Ca21 binding to TnC was character-
ized using light-activated Ca21 chelator experiments and
force-Ca21 (F-pCa) curves.
3. Active tension was deﬁned by the product of the avail-
able actin sites, the maximum isometric tension, and a
sarcomere velocity-dependent scalar. Available actin sites
were calculated from Tm kinetics. Maximum isometric
tension was described by a linear function of SL, with
parameters for this component deﬁned by the maximum
velocity, rapid length step, and sinusoidal perturbation
experimental results.
The model was validated using rapid length-step exper-
iments, caged Ca21 tension transients, clamped and
unclamped SL tension traces, and RT50 as a function of SL.
TROPONIN
Steady-state Ca21 binding to troponin
The ternary cardiac troponin complex (Tn) consists of three
subunits: Troponin I, T, and C. TnC contains the regulatory
Ca21 binding site, where the binding of Ca21 initiates
contraction. Troponin I (TnI) inhibits actin-myosin interac-
tion. Troponin T (TnT) plays a structural role binding to
TnC, TnI, and Tropomyosin (Tm) (12). TnC consists of
N- and C-terminal globular lobes and is connected by a long
central helix. The C-terminal contains binding sites III and
IV, which bind Ca21 and magnesium competitively. Under
physiological conditions, both sites III and IV are saturated.
The N-terminal contains Ca21speciﬁc or low-afﬁnity bind-
ing sites I and II. In skeletal TnC, both sites are active; but in
cardiac TnC, only site II is active, due to an increased
positive charge near site I prohibiting the binding of Ca21
(13). In cardiac TnC, site II regulates muscle contraction and
is the focus of a large number of studies, due to its potential
as a target for Ca21sensitizing drugs and its fundamental role
in excitation-contraction coupling.
Steady-state Ca21 binding to TnC can be described by a
Hill equation with a Hill coefﬁcient of 1 (Eq. 1) (14). Deﬁning
[Ca21]Trpn as the concentration of Ca
21 bound to TnC site II,
[Ca21]TrpnMax, as the maximum concentration of ions that can
bind to site II, [Ca12]i is the concentration of free Ca
21 and K
is the tension-dependent afﬁnity of Ca21 for TnC. K was
determined initially from experimental results with zero or
minimal tension (T) and the tension dependence is considered
below. [Ca21]TrpnMax was set to 70 mM (15,16):
½Ca1 2
Trpn
¼ ½Ca1 2
TrpnMax
½Ca1 2i
½Ca1 2
i
1KðTÞ: (1)
Experimental measurements of Ca21 afﬁnity to site II are per-
formed on a range of species and Tn subunits, under varying
chemical conditions at different temperatures (see Table 1).
The combinations of Tn subunits, Tm, and actin fundamen-
tally affect the Ca21 afﬁnity of site II, as shown in Fig. 2.
TnC in isolation has an afﬁnity of 1 mM (13,17–25). TnC-
TnI, Tn, and Tn-Tm have an afﬁnity of 0.1 mM (13,21–
23,26,27) Tn-Tm-Actin and skinned ﬁbers have an afﬁnity
of 1 mM (22,27–31). However, outliers do exist in the
literature: Fuchs and co-workers (32–34) did not differen-
tiate between sites III and IV and site II afﬁnities. Li and co-
workers (18,24) measured afﬁnities of 2.5 mM and 20 mM
with whole TnC and the N-terminal of TnC containing site
II, respectively, and found no evidence to rationalize the
signiﬁcant variation. Ball et al. (35) measured a higher
afﬁnity of Ca21 to TnC, yet there does not appear to be a
reason for this discrepancy. The effect of magnesium is
varied between experiments, with magnesium having both
minimal (13,23,36,37) and signiﬁcant (25,29) effects; this
may be due to differences in muscle or species types, as a
signiﬁcant difference is seen between rabbit skeletal and por-
cine cardiac muscle (29). Temperature, however, has only a
minimal effect (17,30). Fuchs and co-workers (32–34,38–
44) have shown that Ca21 binding to Tn is dependent on
active tension. In skinned preparations, bound crossbridges
may play a role in determining the binding afﬁnity. How-
ever, the majority of K-values were measured at low [Ca21]
(,2.5 mM) and so tension was assumed to be minimal
(45,46). Ca21 afﬁnity values for Tn bound to actin lie be-
tween 0.83 mM (28) and 5 mM (22) using scintillation
counting and IAANS ﬂorescence with cysteine (Cys) 35 in
place, respectively. It has been suggested that IAANS results
where the Cys amino acid located at residue 35 has been
removed are more accurate than when Cys-35 is present (22).
IAANS results with Cys-35 removed record afﬁnities of 1.6–
2.3 mM (22,29) and scintillation counting recorded afﬁnities
of 2.5 mM (27) and 2.0 mM (47) for TnC in whole ﬁbers;
FIGURE 1 Flow diagram depicting the relationships
of the active contraction framework proposed byHunter
et al. (11). The model is driven by SL and sarcomere
velocity, and intracellular [Ca21]i. Inputs are in bold,
algebraic length dependencies are in italics, processes
described by differential equations are standard font.
1698 Niederer et al.
Biophysical Journal 90(5) 1697–1722
therefore the binding afﬁnity of TnC (K) contained in whole
ﬁbers was set to be 2 mM in the absence of tension. This
value was used in the model and the allosteric affects, if any,
of magnesium binding were assumed to be minimal.
Ca21 binding kinetics
Equation 2 deﬁnes the kinetic binding of Ca21 to site II in
TnC was proposed by Robertson et al. (14). The value kon is
the rate of binding and koff is the tension-dependent rate of
unbinding of Ca21 from TnC. Equation 1 is the steady-state
solution to Eq. 2 with K ¼ koff/kon:
d½Ca21 
Trpn
dt
¼ kon½Ca21 ið½Ca21 TrpnMax
 ½Ca21 
Trpn
Þ  koffðTÞ½Ca21 Trpn: (2)
Large variations are seen in the reported unbinding rates of
Ca21 from site II (koff). Temperature does not appear to have
a signiﬁcant affect on the unbinding rate. The rate lies be-
tween 1.3 s1 and 750 s1 at 4C, 17 s1, and 1200 s1 at
15C, and 13 s1 and 900 s1 at room temperature. It is im-
portant to again note that there is signiﬁcant variation in the
binding afﬁnity (K) of Ca21 for TnC for different combi-
nations of Tn subunits, Tm, and actin, as outlined in the
TABLE 1 Binding afﬁnities of Ca21 to site II of cardiac troponin C
Species Temp (C) Troponin complex Bound Ca21 measure Mg (mM) Kd (M1) K (mM) Ref.
Human 30 NTnC NMRs — 4 3 105 2.5 (18)
Human 15 TnC F27W None 4.2 3 104 24 (25)
Human 15 TnC F27W 3 1.4 3 105 7.1 (25)
Human 30 TnC NMRs — 5 3 104 20 (24)
Bovine 4 TnC SC None 2.5 3 105 4.0 (13)
Bovine 4 TnC SC 4 2.5 3 105 4.0 (13)
Bovine — TnC IAANS 3 7 3 105 1.4 (35)
Bovine 7 TnC F27W — 9.3 3 104 11 (17)
Bovine 21 TnC F27W — 1.9 3 105 5.3 (17)
Bovine 37 TnC F27W — 2.6 3 105 3.9 (17)
Mammal RT TnC IAANS 3 2.5 3 105 4.0 (23)
Mammal RT TnC IAANS None 4.5 3 105 2.2 (23)
Mammal 21 TnC F27W None 2 3 105 5.0 (19)
Rat 4 TnC IAANS (84) 3 3.2 3 105 3.1 (20)
R/B 23 TnC IAANS 3 7.2 3 105 1.4 (21)
Chicken 23 TnC IAANS (84) None 2.9 3 105 3.5 (22)
Chicken 23 TnC IAANS None 3.6 3 105 2.8 (22)
Chicken 23 TnC-TnI IAANS (84) 5 8 3 105 1.3 (22)
Bovine — TnC-TnI IAANS 3 1.5 3 107 0.07 (35)
Rat — TnC-TnI IAANS 3 1.7 3 106 0.59 (26)
R/B 23 TnC-TnI IAANS 3 1.5 3 106 0.67 (21)
Mammal RT TnC-TnI IAANS None 3 3 106 0.33 (23)
Bovine 4 TnC-TnI SC 4 1 3 106 1.0 (13)
Bovine 4 TnC-TnI SC None 1 3 106 1.0 (13)
Chicken 23 Tn IAANS 5 1.2 3 106 0.83 (22)
Bovine 4 Tn SC None 2.5 3 106 0.40 (13)
Bovine 4 Tn SC 4 2.5 3 106 0.40 (13)
Bovine 25 Tn-Tm IAANS 2.5 1.2 3 106 0.83 (27)
P/C* RT SP IAANS (84) 1 6.3 3 105 1.6 (29)
R/C RT SP IAANS (84) 1 6.3 3 105 1.6 (29)
Bovine 25 SP SC 5 4 3 106y 0.25 (33)
Bovine 25 SP SC 5 2 3 106y 0.50 (32)
Bovinez 25 Tn-Tm-A SC 2.5 4 3 105 2.5 (27)
Bovine 25 Tn-Tm-A SC 2.5 9.6 3 105 1.0 (27)
Bovine 25 Tn-Tm-A IAANS 2.5 1.1 3 106 0.91 (27)
Bovine 25 SP SC 5 2 3 106y 0.5 (34)
R/C 23 SP IAANS 1 2 3 105 0.5 (22)
R/C 23 SP IAANS (84) 1 4.7 3 105 2.1 (22)
Canine 25 SP SC 2, 10 1.2 3 106 0.83 (28)
Canine 25 SP SC 2 2.36 3 105 4.2 (31)
IAANS is IAANS-labeled TnC; IAANS (84) is IAANS-labeled TnC, with Cys amino acids at residue 84; NMRs is NMR spectroscopy; None ¼ ,1 3 10–3 mM;
P/C is porcine ﬁber with chicken TnC; R/B is rat ﬁber/bovine Tn-Tm; R/C is rat ﬁber with chicken TnC; SC is scintillation counting; and SP is skinned preparation.
RT is room temperature.
*BDM added.
yAfﬁnity for sites II, III, and IV combined.
zIAANS bound, but not used to measure afﬁnity.
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above section (see Fig. 2). The variation in K will be re-
ﬂected in the kinetics by a change in the ratio of unbinding
and binding rates with different combinations of Tn
complexes. Unbinding rates for TnC bound to Tn-Tm, Tn-
TnI, and Tn are in the order of 10 s1 (47–49), which
coincide with the higher reported afﬁnities for the same Tn
complexes (center column of Fig. 2). TnC in isolation has
varied unbinding rates between 11 s1 and 5000 s1 and a
lower binding afﬁnity (illustrated in the right column of
Fig. 2). The majority of binding rates lie within a factor of 2
of 100 mM1 s1 (20,25,48,50–53) (see Table 2) with no
apparent variation between temperatures or combinations of
Tn subunits and Tm. Binding and unbinding rates have not
been measured in whole ﬁber preparations. To determine the
rates in whole ﬁbers, it was assumed that it was primarily the
unbinding rate, and not the binding rate, which changes for
different TnC complexes, resulting in the changes in binding
afﬁnity (K) reported above. This assumption is consistent
with the hypothesis that binding of Ca21 to site II is diffu-
sion-limited (54). The binding rate was set to 100 mM1 s1,
and using the afﬁnity of Ca21 for TnC derived above from
Table 1 of 2 mM, the unbinding rate for site II of TnC
contained in Tn-Tm-actin was koff ¼ K  kon¼ 200 s1.
Tension-dependent Ca21 unbinding rate
from Troponin C
The tension-dependent binding of Ca21 to TnC has been
elucidated via a number of discrete experimental techniques.
The afﬁnity of Ca21 for TnC decreases during rapid step-
length reduction experiments on intact muscle (55–57). The
concentration of Ca21 bound to TnC decreases when tension
development is inhibited with vanadium (33,40). Modeling
experiments using Ca21-sensitizing drugs indicate that Ca21
binding to TnC is likely to be tension-dependent (58). The
tension-dependent unbinding rate from Eq. 2 is deﬁned by
Eq. 3, below. The form of Eq. 3 captures tension-dependent
components of Ca21 binding to site II of TnC as well as the
length-dependent components, as discussed below.
koff ¼ krefoff 1 T
gTref
 
; (3)
where krefoff is the unbinding rate in the absence of tension,
g is a measure of the affect of tension on the unbinding rate,
T is the active tension, and Tref is the reference tension
(described below). The value g is not measured directly
experimentally but can be calculated using results from Ca21
FIGURE 2 Afﬁnity of Ca21 to TnC contained in various components of
mammalian cardiac thin ﬁlaments, from studies listed in Table 1. The plus-
symbol (1) is scintillation counting; s is IAANS (Cys-35, Cys-84); 3 is
IAANS (Cys-35);;is F27W; and h is MRI spectroscopy.
TABLE 2 Binding and unbinding rates of Ca21 to site II in TnC
Species Muscle Temp (C) Troponin complex Bound Ca21 measure Kon (mM1 s1) Koff (s1) Ref.
Rabbit S 4 TnC F29W 100–200 — (50)
Rabbit S 4 TnC DANZ 100–200 — (50)
Rabbit S 15 TnC F29W 100 340 (51)
Rabbit S 22 TnC F29W — 350 (50)
Rabbit S 22 TnC DANZ — 551 (50)
Rabbit S 22 TnC Quin-2 290 462 (50)
Human C 4 TnC IAANS — 73 (52)
Human C 15 TnC F27W 170 1159–1263 (25)
Human C 20 TnC IAANS 100 483 (52)
Human C 30 TnC NMRs 250 5000 (24)
Bovine C 4 TnC IAANS 51 11 (48)
Bovine C 15 TnC Quin-2 — 136.5 (49)
Chicken C 4 TnC Quin-2, BAPTA 200–400 700–800 (53)
Rat C 4 TnC IAANS 140 437 (20)
Bovine C 4 TnC-TnI IAANS 59 12 (48)
Bovine C 15 Tn-Tm IANDB — 16.2–18.2 (49)
Bovine C 15 Tn-Tm Quin-2 — 23 (49)
Chicken S 4 Tn-Tm IANDB 10 1.3 (47)
Chicken S 20 Tn-Tm IANDB 65 13 (47)
Model C N/A SP — 39 19.6 (14)
C is cardiac; S is skeletal.
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afﬁnity and length-step experiments in skinned and intact
preparations, respectively. As now discussed, calculating g
in both intact and skinned preparations conﬁrms that the
tension-dependent binding of Ca21 to TnC is not affected by
the skinning process.
Fuchs and co-workers have shown that the concentration
of bound Ca21 is both tension- (33,40,44) and length-de-
pendent (32,38,40,42,44) in skinned preparations. However,
it is likely that these two dependencies are related by the
number of attached crossbridges (55), which increases with
length (59) and has been shown to increase the binding
afﬁnity of Ca21 for TnC (47). The tension dependence of
Ca21 binding to TnC is consistently supported by the results
within individual experiments. Comparing results between
experiments, however, reveals inconsistencies. In the ab-
sence of bound crossbridges due to the addition of vanadate,
between 75% (33,40) and 50% (44) of site IIs are
occupied at pCa ¼ 5. It was then expected that, if tension
were the only factor determining the binding of Ca21 to TnC,
then at pCa ¼ 5, no less than 50–75% of sites should be
occupied in the presence of tension, yet measurements of
35% (32), 49% (44), and 69% (42) of site IIs occupied at pCa
5 in the presence of tension have been reported. The
variation can be rationalized by three potential mechanisms.
Firstly, that some mechanism other than bound crossbridges
affects afﬁnity. Secondly, variations between preparations
affected the results. Thirdly, the method used here to
calculate the number of ions bound to site II introduces or
increases variation in the measurements. Fuchs and co-
workers measured the total concentration of Ca21 bound to
all three sites of TnC. As sites III and IV are known to have a
higher afﬁnity than site II it was assumed that they are both
saturated at pCa 5. Therefore the fraction of site IIs occupied
by Ca21 is equal to the total number of ions bound per TnC
molecule less two. As a result, the fraction of site IIs
occupied by Ca21 is sensitive to experimental noise. If, on
average, a total of 2.8 ions are bound to TnC at pCa¼ 5, then
a variation of 3.6% (32) in the total number of ions bound to
TnC corresponds to a variation of 0.1 ions. Subtracting the
two ions bound to the saturated sites III and IV from the total
number of ions bound (2.8 ions) means that there is a 0.1 ion
variation in the remaining 0.8 ions bound to site II, which
corresponds to a 12.5% variation in the number of ions
bound to site II. This ampliﬁcation of the experimental noise
potentially explains the variation in experimental results
observed. The afﬁnity of Ca21 for TnC in the absence of
tension derived from Table 1 was 2 mM, which corresponds
to 83% of site IIs being occupied at pCa 5 in the absence of
tension, comparable with measurements of 75% (33,40).
The value g was determined using the K-value in the absence
of tension deﬁned above and a subset of results from Table 3.
Results from experiments where Dextran or Vanadate were
added, when the average SL was outside the physiological
range of 1.8–2.3 mm or when the fraction of bound Ca21 is
,83% at pCa 5 (the value deﬁned by Eq. 1 at zero tension),
were excluded from the subset. The ﬁnal subset took results
from Fuchs and co-workers (32,33,38,42,44); g was deter-
mined for each measurement, and the average g-value was 1.9.
To ensure that the skinning procedure did not affect the
tension dependence of K, skinned results were compared
with intact values. In intact preparations, length-step exper-
iments elucidate the value of g. Results by Allen and Kentish
(56), using the Ca21 released during length step experiments,
estimated that the afﬁnity of Ca21 for TnC (K) would halve
when tension was dropped to zero during a length step
corresponding to a g-value of 2. Komukai et al. (57) found a
linear relationship between D[Ca12]i/[Ca
12]i (the ratio of the
quantity of Ca21 released during a step change to the free
Ca21 before a length change) with the tension before by the
length change (T1) as tension increased (see Eq. 4). The size
of the length steps were deﬁned such that the tension after the
length change was equal to zero:
D½Ca21 i
½Ca21 i
¼ 0:0066T1: (4)
Equations 5 and 6 deﬁne the concentration of bound Ca21
before and after the length-step change, respectively, using
Eq. 1, and the Ca21 afﬁnity is an unknown function of
tension K(T),
TABLE 3 Ca21 bound to bovine cardiac troponin C site II
Temp (C) Additives
Sarcomere
length (mm)
Fraction of
site II with
bound Ca21 Ref.
22 None 1.5–1.6 0.49 (44)
22 None 1.7 0.83 (38)
— None 1.7 0.69 (42)
RT None 1.74 0.25 (40)
25 None 1.81 0.35 (32)
22 None 1.9 0.80 (43)
22 None 2.2–2.3 1 (44)
22 None 2.2–2.3 1 (44)
22 None 2.3 1 (38)
— None 2.3 0.94 (42)
25 None 2.34 1 (32)
25 None 2–2.5 1 (33)
RT None 2.45 1 (42)
22 2% dextran 2 1 (38)
22 5% dextran 1.7 1 (38)
— 5% dextran 1.7 1.0 (42)
— 5% dextran 2.3 1.0 (42)
22 5% dextran 1.9 1.0 (43)
22 10% dextran 1.9 0.80 (43)
22 15% dextran 1.9 0.26 (43)
25 1 mM Vi 2–2.5 0.74 (33)
RT 1 mM Vi 2.28–2.34 0.72 (40)
RT 1 mM Vi 1.52–1.78 0.72 (40)
22 1 mM Vi 2.2–2.3 0.50 (44)
RT is room temperature. Bound calcium is calculated using 0.34 mmol
troponin/g of ﬁber. Bovine cardiac muscle at pCa5 is used in all cases. It is
assumed that, at pCa 5.0, the high-afﬁnity sites are saturated. If total
calculated bound Ca21 was .3, it is assumed that site II is saturated. It is
assumed T T0 at pCa5, in the absence of any additives.
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½Ca21 
Trpn
¼ ½Ca21 
TrpnMax
½Ca21 i
½Ca21 
i
1KðT1Þ
; (5)
½Ca21 Trpn D½Ca21 i ¼ ½Ca21 TrpnMax
3
½Ca21 i1D½Ca21 i
½Ca21 i1D½Ca21 i1KðT ¼ 0Þ
:
(6)
Combining Eqs. 5 and 6, and assuming [Ca21]TrpnMax 
D[Ca21]i (56),
½Ca21 iKðT1Þ  KðT ¼ 0Þ  ð½Ca21 i1D½Ca21 iÞ  0:
(7)
Now the Ca21 tension relationship deﬁned in Eq. 4 can be
used to transform Eq. 7 from a Ca21-dependence of K to a
tension-dependence of K. Using Eq. 4 proposed by Komukai
and K(T ¼ 0) is equal to the afﬁnity of Ca21 to site II in the
absence of tension (K):
KðT1Þ ¼ KðT ¼ 0Þ  11D½Ca
21 i
½Ca21 i
 
¼ Kð1 0:0066T1Þ:
(8)
Setting Eq. 8 equal to Eq. 3 divided by kon, g is equal to 2.6,
using Tref ¼ 56.2 kPa. The calculated g-value of 1.9 from
Fuchs and co-workers for skinned preparations is close to
calculated g-values in length-step experiments in intact pre-
parations and suggests that the skinning process has a mini-
mal affect on the tension dependence of Ca21 binding to TnC.
The Ca21 afﬁnity for TnC has also been shown to vary
with SL (32,40,44). In length-step experiments, the afﬁnity
of TnC drops signiﬁcantly but the SL remains largely
unchanged. The g -value required to capture this phenom-
enon is close to the g-value required to model the change in
calcium afﬁnity at varying ﬁxed SL values. Hence, the SL
dependence of the afﬁnity is accounted for by the tension
dependence, as maximum tension and tension-based Ca21
sensitivity increase with increasing SL (discussed below).
This hypothesis coincides with experiments, where cross-
bridge heads (myosin subfragment 1) bound to actin in
the absence of myosin or any reference length increased the
binding afﬁnity of Ca21 for TnC (47). In the model, the
length dependence is accounted for by the tension depen-
dence and the form of the equation is validated by Komukai’s
results. Considering these results g will be set to 2.
TROPOMYOSIN
Tropomyosin is a highly extended a-helical coil situated in
the actin groove, with each tropomyosin molecule spanning
seven actin monomers (27). When tropomyosin is shifted out
of the actin groove, the steric hindrance preventing actin
binding to myosin is removed, allowing tension to develop.
In the model, tropomyosin was characterized by z, the
fraction of actin sites available for crossbridge binding. In
this study, it is assumed that crossbridges bind rapidly
relative to thin ﬁlament kinetics and that not all actin sites are
available at full activation. Thus, tension is proportional to z
and the ratio of z to the fraction of actin sites available at full
activation for a given SL (z/zMax) is equal to the ratio of the
isometric tension to the maximum tension at full activation
for the same SL (T0/T0Max). The value z is deﬁned by Eq. 9,
below. The fraction of actin sites available at full activation
(zMax) is deﬁned by Eq. 14, the steady-state solution to Eq. 9
at full activation ([Ca21]Trpn ¼ [Ca21]TrpnMax). The value T0
is the isometric tension at a given [Ca21]i and SL (see Eq.
16). The value T0Max is the isometric tension at full activation
for a given SL (see Eq. 15).
dz
dt
¼ a0
½Ca21 
Trpn
½Ca21 Trpn50
 !n
ð1 zÞ  ar1z ar2 z
nr
z
nr 1KnrZ
; (9)
where the relaxation kinetics in Eq. 9 are described by ar1
and ar2, Kz and nr, which correspond to the slow and fast
relaxation rates, respectively, observed in light-activated
Ca21 chelator experiments. The tension transients produced
in light-activated Ca21 chelator experiments are potentially
deﬁned by three mechanisms—the [Ca21]i bound to TnC,
crossbridge kinetics, or the intrinsic properties of tropomy-
osin. The rate that tension decreases is signiﬁcantly slower
than the rate that calcium disassociates from TnC and, as
such, the rate of relaxation is unlikely to be deﬁned by
[Ca21]i bound to TnC. The rate that tension decreases after
a step decrease in Ca21 is similar between species (rat
(60–63) and guinea pig (5,64,65)) exhibiting different myo-
sin isoforms, suggesting that crossbred kinetics do not deﬁne
relaxation rates. Palmer and Kentish observed signiﬁcant
differences between guinea pig and rat preparation relaxation
rates of 16.1 s1 and 2.99 s1, respectively. However, their
results are inconsistent with other experimental observations,
which have consistently reported guinea pig relaxation
rates of 10 s1 and above (5,64,65). As such, the intrinsic
properties of tropomyosin are assumed to be deﬁned by the
tension transients after step decreases in calcium. The length-
dependent activation kinetics are described by [Ca21]Trpn50,
a0, and n. The value [Ca
21]Trpn50 is the Ca
21 bound to TnC
at half-activation and was derived from the free Ca21 at half-
activation. The value a0 describes the monoexponential
activation rate seen in caged Ca21 experiments. The value
n is analogous to the Hill coefﬁcient in the steady-state force
Ca21 curve (F-pCa) and provides a phenomenological rep-
resentation of the high cooperativity, due to nearest-neighbor
interactions between tropomyosin and/or crossbridges, seen
in the activation of tension in cardiac muscle.
Tropomyosin kinetics are described in four stages, which
were cyclically iterated through. Brieﬂy, ﬁrst, the relaxation
parameters (ar1, ar2, Kz, and nr) are deﬁned using step
changes in Ca21 experiments. Secondly, length-dependent
activation ([Ca21]Trpn50) is deﬁned using half-activation
values from skinned preparations and the resulting equation
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is scaled to match intact preparation data. Thirdly, a0 and
n are deﬁned for skinned and intact preparations by ﬁtting the
steady-state solution of Eq. 9 to the respective F-pCa curves.
Finally, zMax—the fraction of actin sites available at maxi-
mum activation—is calculated using the steady-state solu-
tion to Eq. 9.
Relaxation parameters
The relaxation kinetics described by Eq. 9 propose two
stages for relaxation, as seen experimentally. It was found
that a linear component involving ar1 characterized the slow
process and a nonlinear component in the form of a Hill
relation was required to model the fast component. Using the
combined linear and nonlinear off-rates, the biphasic nature
of relaxation was captured. To compare model simulations
with experimental results, the relative tension T0/T0Max
(or equivalently, T/T0 in experimental nomenclature) was
calculated using T0/T0Max¼ z/zMax, where zMax is deﬁned
below by Eq. 14.
The relaxation components of Eq. 9 were ﬁtted using the
tension transient after a step decrease in free Ca21 using the
light-activated Ca21 chelator diazo-2. Ca21 disassociates
rapidly from TnC after a step decrease in Ca21i and was
therefore expected to have a minimal affect, such that the
relaxation kinetics of tropomyosin solely determine the
tension transient. In Ca21 step experiments the muscle is
often removed from the bathing solution and exposed to a
pulse of light, which greatly increases the afﬁnity of diazo-2
for Ca21, causing a reduction of free Ca21 on a millisecond
timescale. Data from rat and guinea pig preparations were
used with both similarities and dissimilarities between species
being observed. Experiments are commonly performed in air
at the due temperature to reduce the affects of evaporation or
condensation. As such, most experiments are performed at
12–15C with the exception of results from Kentish and
Palmer (63,66), where the muscle was kept in the bathing
solution at 20–22C. Results from diazo-2 experiments are
summarized in Table 4. A biphasic tension transient is
observed in most experiments, which is ﬁtted with two expo-
nentials. The rates are 10–12 s1 and 2–4 s1, respec-
tively, at 12–15C for rat and guinea pig (60,62,64,65); and
16–18 s1 and 1 s1 at 22C for rat in two other studies,
respectively (63,66). The sole anomaly was recorded by
Saeki et al. (61), who reported a fast transient of 73.5 s1, six
times larger than any other experiment. The subsequent
article by the same group using similar methods did not
record the higher transient rate, and made no reference to
their earlier results (60). The tension transients recorded by
Simnett et al. (65) at 20C had a half-time to relaxation of
53.4 ms, approximately the same as the control rat mea-
surements at 15C from Fitzimons et al. (62), which had a
half-time to relaxation of 64.5 ms. However, removing the
muscle from the bath would result in a drop in temperature of
2–3C (65), and during activation, ADP and Pi can build up
in preparations removed from the bath (63), both of which
would affect relaxation. Palmer and Kentish (63,66) re-
corded relaxation times using rat trabeculae contained in the
bathing solution, reducing any buildup of Pi or ADP and
attaining data at 22C, but characteristic tension traces pub-
lished by Palmer and Kentish had a maximum tension of
0.3 T0. The relaxation parameters were chosen to ﬁt
experimental results from Saeki et al. (60) and Simnett et al.
(65) at 12–15C, since an accurate ﬁt to all data was not
possible with limited information on SL (6,64), relative
amplitudes of fast and slow processes (62,66), and initial
TABLE 4 Light-activated calcium chelator tension relaxation transients
Species Prep Temp (C) Initial pCa SL (mm) T1/T0 T2/T0 P1 k1(s1) P2 k2(s1) Ref.
Rat T 14–15 5.8 2.2 0.5 0.05 18.9 73.5 85.3 9.8 (61)
Rat T 14–15 6.1 2.2 — — 93 12.1 8 2 (60)
Rat T 14–15 5.8 2.2 — — 93 12.1 8 2 (60)
Rat T 14–15 5.6 2.2 — — 93 12.1 8 2 (60)
GP T 12 — 2.2 1 0 49 10.0 51 4.23 (65)
GP T 20 — 2.2 1 0 92 18.4 15 2.52 (65)
Rat T 22 — 2.1 0.4 0.1 — 16.1 — 0.97 (66)
GP T 22 — 2.1 0.61 0.33 — 2.99 — — (66)
GP T 12 — — 1 0 45 11.2 57 2.9 (64)
Rat V 15 5.5 2.3 0.48 0 — 10.8* — — (62)
Pig V — — — 0.8 0 — 6.3* — — (6)
Rat T 22 5.56 2.1 — 0 46 16.6 54 1.1 (63)
Rat T 22 5.56 2.1 — 0 48 17.3 52 1.3 (63)
GPyz V 10 4.5 2.25–2.4 1 0 — 12 — 0.3 (5)
Mousez V 10 4.5 2.25–2.4 1 0 — 18 — 1.8 (145)
GPz T 10 4.5 2.25–2.4 1 0 — 10.8 — 0.6 (145)
Humanz T 10 4.5 2.25–2.4 1 0 — 4.6 — 0.15 (145)
SL is sarcomere length. GP is guinea pig. T is trabeculae; V is ventricle.
*Calculated from half-time of relaxation. [Ca21] was rapidly decreased using diazo-2.
yStehle et al. (5,145) ﬁtted a piecewise function containing a linear region with a slope equal to k2 and an exponential region with rate k1.
zUsed rapid solution changes to change [Ca21].
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tension (63). Fig. 3 shows results from Saeki et al. (60)
(points) and model simulations (lines) with ar1, ar2, Kz, and
nr equal to 2 s
1, 1.75 s1, 0.15, and 3, respectively.
Activation parameters
Having deﬁned the parameters corresponding to relaxation,
the remaining parameters could be ﬁtted using caged Ca21
tension transient experiments or F-pCa curves. Caged Ca21
experiments are principally performed over a narrow range of
SL, inhibiting their ability to characterize any length depen-
dence. F-pCa curves, which are performed over a wide range
of SLs, are used to characterize the remaining parameters.
F-pCa curves were used to deﬁne steady-state z in the
solution of Eq. 9 using the commonly ﬁtted experimental
relationship in Eq. 10. The F-pCa relationship was described
by a Hill curve with half-activation [Ca21]50 and Hill
coefﬁcient nH. These two variables are commonly recorded
experimentally (see Table 5),
z
zmax
¼ T0
T0max
¼ ½Ca
21 nHi
½Ca21 nH
i
1 ½Ca21 nH
50
: (10)
The activation parameters in Eq. 9 were deﬁned using F-pCa
curves in two parts. First, the length-dependent activation
was deﬁned by determining the length dependence of
[Ca21]Trpn50, which was calculated from the length-
dependent [Ca21]50 values deﬁned in Eq. 10 from skinned
and intact preparations by rearranging the equations outlined
above. Secondly, a0 and n were determined by ﬁtting the
steady-state solution to Eq. 9 to F-pCa curves. The F-pCa
curves were deﬁned by the half-activation values used to
calculate [Ca21]Trpn50 and Hill coefﬁcients for skinned and
intact preparations.
Length-dependent activation
[Ca21]50 is dependent on SL, which is seen as a leftward shift
in the F-pCa curve as SL increases (67–70). The increased
sensitivity has been associated with axial stretch (46), in-
terﬁlament spacing (44), bound crossbridges kinetics (71),
and titin (72). Fuchs et al. (38,42–44) and McDonald and
Moss (73) found that ﬁber width predominantly determined
length-dependent Ca21 sensitivity. Then, using ﬁber width
as an indicator of interﬁlament spacing, they concluded that
interﬁlament spacing determined length-dependent Ca21
sensitivity. Recently, Konhilas et al. (74) measured interﬁla-
ment spacing using x-ray diffraction, and showed that ﬁber
width is a poor indicator of interﬁlament spacing and that
interﬁlament spacing does not affect length-dependent Ca21
sensitivity. Moss and Fitzsimons (75), in their critical review
of the results of Konhilas et al. (74), acknowledged the
technical difﬁculties of the experiments and the potential for
experimental error, but also believe that this does not detract
from the fundamental ﬁnding that myoﬁlament spacing is not
the predominant cause of the length dependence of Ca21
sensitivity. Unfortunately few other hypothesis exist to ac-
count for this phenomenon (75,76), though modeling results
from Rice and de Tombe (76) suggest the possibility that
cooperative effects between the regulatory units (troponin
and tropomyosin) could account for increased Ca21 sensi-
tivity at longer SLs.
[Ca21]Trpn50 is deﬁned by Eq. 11, derived from Eq. 15 and
Eq. 2, as a function of [Ca21]50 values and strain. Eq. 15 is
deﬁned below, and describes the length dependence of iso-
metric tension. Here it was used to deﬁne the ratio between
T/Tref from Eq. 2 as a function of strain:
½Ca12
Trpn50
¼ ½Ca21 
TrpnMax
3
½Ca21 50
½Ca21 
50
1 krefoff
kon
1 ð11b0ðl1ÞÞ3 0:5
g
 : (11)
[Ca21]50 values contained in Eqs. 11 and 10 were deﬁned as
a linear function of strain (see Eq. 12). Fig. 4 plots [Ca21]50
values for measurements taken under physiological condi-
tions at room temperature in Table 5 against strain. The
length-dependent Ca21 sensitivity was deﬁned in terms of a
linear ﬁt to the Ca50 values. Data was taken predominantly
from rats at room temperature under physiological condi-
tions (45,66,77–84). Data was excluded on the grounds of
extreme (SL , 1.8 mm, SL . 2.3 mm) or unstated SLs
(57,77,85), low levels of ATP (,4 mM) (80), low ionic
strength (86,87) (,180 mM), and low or unstated tempera-
tures (46,79,88) (,20C). Intact muscle experiments (2,3,89)
are considered separately below. The relationship between
[Ca21]50 and strain is described by Eq. 12 with [Ca
21]50ref ¼
4.72 mM and b1 ¼ 4.0 in skinned preparations,
FIGURE 3 Relaxation after activation of Ca21 chelator; data points from
Saeki et al. (60), and lines are from model simulations. The ; data points
and dashed line, n data points and dotted line, and ¤ data points and solid
line had initial relative tensions of 0.5, 0.451, and 0.0925, respectively, and
the pCa values after the activation of the calcium chelator were 5.78, 5.92,
and 6.3, respectively. The pCa values were calculated using the ﬁnal relative
tensions and the skinned F-pCa curve deﬁned below with a Hill coefﬁcient
of n ¼ 3 and half-activation value of pCa50 ¼ 5.6. SL ¼ 2.2 mm.
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½Ca21 50 ¼ ½Ca21 50refð11b1ðl 1ÞÞ: (12)
Backx et al. (2) reported signiﬁcant differences in Ca21
sensitivity of skinned muscle compared to intact muscle—
half-activation is 2–10-fold larger and the Hill coefﬁcient is
2–3 times smaller in skinned muscle. The change in steady-
state calcium sensitivity can potentially be rationalized by
three different mechanisms:
First, due to intracellular proteins and ions, the spatially
averaged Ca21 concentration measured in ﬂuorescence
studies does not represent the true concentration of Ca21
in the vicinity of the myoﬁbrils and therefore the concen-
tration of Ca21 at the myoﬁbrils is 2–10 times larger at half-
activation (89,90). In this case, the concentration of Ca21
presented to TnC can be scaled by a factor of 2–10, relative
to the spatially averaged measures.
Second, the skinning and storage process may reduce the
concentration of TnC (91), change the chemical environment
(90), or alter the degree of phosphorylation of TnI (92)
resulting in a change in the afﬁnity of Ca21 to TnC. This can
be represented by increasing the afﬁnity of Ca21 to TnC.
Third, skinning, storage, and a change in chemical
environment may cause changes to myosin, actin, tropomy-
osin, or titin, and the concentration of Ca21 bound to TnC
required to cause half-activation may be signiﬁcantly less in
intact preparations and the cooperative mechanisms repre-
sented by the Hill coefﬁcient may be degraded (93,94).
TABLE 5 Rat tension-free calcium sensitivity
Species Muscle Temp (C) Ionic strength Mg21 (mM) ATP (mM) Sarcomere length (mm) pCa50 n1 n2 Ref.
Rat T 22–24 200 3 5 1.65 5.02 4.35 — (45)
Rat T 15 200 1 5 1.85 5.35 4.8 8.6 (46)
Rat V 15 180 — 4.74 1.85 5.41 — 3.4 (71)
Rat T 22–24 200 3 5 1.75 5.11 2.82 — (45)
Rat T 22–24 200 3 5 1.85 5.17 3.85 — (45)
Rat V 22–26 160 3 3 1.9 5.5 3.2 — (86)
Rat T 15 180 1 5 1.95 5.47 6.5 — (83)
Rat T 15 180 1 5 1.95 5.47 6.34 — (74)
Rat T 15 200 1 5 1.95 5.39 4.7 11 (46)
Rat T 22–24 200 3 5 1.95 5.27 3.91 — (45)
Rat T 20 200 0.3 3 1.9–2.04 5.26 2.37 — (77)
Rat T 23.8 200 1 5 2.0 5.36 — — (78)
Rat T 23.8 200 1 5 2.0 5.36 — — (82)
Rat T 15 200 1 5 2.05 5.43 5.4 9.9 (46)
Rat T 22–24 200 3 5 2.05 5.36 4.5 — (45)
Rat V RT 160 3 3 2.0–2.1 5.73 3.1 — (87)
Rat T 15 180 1 5 2.1 5.5 6 — (74)
Rat T 15 180 1 5 2.1 5.51 6.01 — (83)
Rat T 20 230 1.5 5 2.1 5.54 5.98 — (80)
Rat T 23.8 200 1 5 2.1 5.47 — — (82)
Rat T 23.8 200 1 5 2.1 5.47 — — (78)
Rat T 22 200 1 6.3 2.14 5.6 3.05 — (66)
Rat T 15 200 1 5 2.15 5.45 5.6 8.8 (46)
Rat T 22–24 200 3 5 2.15 5.42 4.54 — (45)
Rat V 15 180 — 4.74 2.2 5.51 — 3.2 (71)
Rat V 15 182 1 5 2.2 5.62 3.1 — (88)
Rat V 22 180 1 4 2.2 5.74 2.33 — (84)
Rat T 23.8 200 1 5 2.2 5.63 — — (82)
Rat T 23.8 200 1 5 2.2 5.63 — — (78)
Rat T 15 180 1 5 2.25 5.56 5.34 — (74)
Rat T 15 200 1 5 2.25 5.49 4.7 7.3 (46)
Rat T 15 180 1 5 2.25 5.56 5.4 — (83)
Rat T 20–22 — 0.5 5 2.2–2.3 6.0 3.75 — (89)
Rat T 20–22 — 1.2 5 2.2–2.3 5.65 2.72 — (89)
Rat V 22–26 160 3 3 2.3 5.89 4.01 — (86)
Rat V 10 200 1 4 2.31 5.36 — — (79)
Rat V 15 200 1 4 2.31 5.68 1.85 3.5 (79)
Rat V 22 200 1 4 2.31 5.84 — — (79)
Rat T 20 200 0.3 3 2.3–2.5 5.48 2.7 — (77)
Rat* T 20–22 — 0.72 — 2.2–2.3 6.2 4.87 — (89)
Rat* T 20–22 — — — 2.2 6.2 — — (95)
Rat* T 20–22 — — — 2.1–2.3 6.19 5.2 — (2)
T is trabeculae; V is ventricle. RT is room temperature.
*These preparations were not skinned.
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Assuming that the affects of skinning on TnC does not
alter the capacity of ﬂuorescence data to represent a scalable
weighted average of bound Ca21, free Ca21 in the vicinity of
the myoﬁlaments is independent of skinning, assuming
the myoﬁlament charge remains unchanged. Then most of the
observed changes in Ca21 sensitivity will be a result of the
protein–protein interactions after binding of Ca21 to TnC.
Hence the affect of skinning can be represented by changing
the [Ca21]50ref. Three studies on intact rat preparations with
SLs of 2.2 mm calculated the pCa50 value to be 6.2
(2,89,95), which compares with a value of 5.6 for skinned
preparations (71,78,82,84,88). [Ca21]50ref for intact prepa-
rations was scaled to account for the variation between intact
and skinned preparations, resulting in a [Ca21]50ref value of
1.05 mM in intact preparations. This deﬁnition of [Ca21]50ref
takes into consideration the affects of changes in the
chemical environment or degradation of the myoﬁlaments.
Insufﬁcient data was available to accurately characterize the
length dependence of activation in intact cells, and as a
result, b1 was assumed independent of the skinning process.
Steady-state F-pCa curve
F-pCa curves were deﬁned by [Ca21]50 and the Hill
coefﬁcient. The pCa50 values deﬁned above at l ¼ 1.1 were
5.6 and 6.2 for skinned and intact preparations, respectively.
The Hill coefﬁcient has been shown to be both length-
dependent (45) and independent (46,73) experimentally.
Recent studies by Dobesh et al. (46) showed no length
dependence of the Hill coefﬁcient when SL was accurately
controlled during contraction. Kentish et al. (45) reported a
strong length-dependence of the Hill coefﬁcient, but also
reported signiﬁcant sarcomere shortening during contraction,
which potentially distorted their results. Here, we assumed
that the Hill coefﬁcient is independent of length. A Hill
coefﬁcient of 5 was taken from the F-pCa curve for l ¼ 1.1
observed by Gao et al. (89), Backx et al. (2), and You et al.
(96) for intact rat preparations at room temperature. In skinned
preparations, Hill coefﬁcients values range between 1.9 and
10.6. At room temperature, for l ¼ 1.1, the Hill coefﬁcient
was 3. It is possible that these curves underestimate the Hill
coefﬁcient due to uncontrolled sarcomere shortening as
proposed by Dobesh et al. (46), but Dobesh used skinned
preparations at 15C and it is hard to quantify the effect these
conditions would have on the Hill coefﬁcients.
The values a0 and n were found by ﬁtting the steady-state
solution of Eq. 9 to F-pCa curves using Eq. 10. The steady-
state solution of Eq. 9 was solved iteratively as a function of
bound Ca21. The bound Ca21 was calculated using tension
from F-pCa curves deﬁned by half-activation values and Hill
coefﬁcients deﬁned above. The resulting values for a0 and n
were 6 s1 and 3.4 and 8 s1 and 3 for skinned and intact
preparations, respectively. Fig. 5 shows the ﬁtted F-pCa and
idealized F-pCa curves at l ¼ 1.1. The dashed and dash-dot
lines were calculated from pCa50 values 5.6 and 6.2 and Hill
coefﬁcients 5 and 3 for skinned and intact preparations,
deﬁned above. Solid and dotted lines were generated by the
model using the skinned and intact parameter sets.
Maximum activation
In this study, it is assumed that, at maximum activation, not
all actin sites are available. However, to ensure that when
TnC was saturated the maximum tension reported experi-
mentally was achieved, z was normalized by zMax, such that
when [Ca21]Trpn ¼ [Ca21]TrpnMax,, z/zMax ¼ 1 and T0 ¼
T0Max. The value zMax was calculated by solving Eq. 9 with
dz/dt ¼ 0 and [Ca21]Trpn ¼ [Ca21]TrpnMax. This is a
nonlinear equation and requires an iterative solution method.
To maintain an explicit formulation for the model, the non-
linear component was linearized around a point zp using a
Taylor expansion to equal zK11K2, where K1 and K2 are
FIGURE 4 Calcium value at half-activation as a function of strain with
resting SL¼ 2 mm. (Solid line) Points ﬁtted to [Ca21]50¼ 4.72(1–4.0(l1)).
FIGURE 5 Relative steady-state tension with respect to free pCa value.
The dashed and dot-dashed lines are calculated from Eq. 10, with pCa50
values 5.6 and 6.2 and Hill coefﬁcients 5 and 3 for skinned and intact
preparations, respectively, at l¼ 1.1. Solid and dotted lines are generated by
the model using the steady-state solution to Eq. 9, with the intact and skinned
parameters, respectively.
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deﬁned by Eq. 13. The value zp was set to 0.85 and ensures
an error of ,1% for z 2 [0.6,1.0],
K2 ¼ ar2
z
nr
p
z
nr
p 1K
nr
Z
1 nrK
nr
Z
ðznrp 1KnrZ Þ
 !
; K1 ¼
ar2z
nr1
p nrK
nr
Z
ðznrp 1KnrZ Þ2
:
(13)
The value zMax is then deﬁned by solving the linearized Eq. 9
with dz/dt ¼ 0 and [Ca21]Trpn ¼ [Ca21]TrpnMax, giving
zMax ¼
a0
½Ca21 nTrpn50
 K2
ar11K11
a0
½Ca21 nTrpn50
: (14)
TENSION DEVELOPMENT
Isometric tension
Isometric tension is described in two parts. First, the
maximum tension at full activation for a given SL (T0Max) is
deﬁned using experimentally reported tensions at pCa # 4.
Secondly, the isometric tension as a function of SL and the
fraction of available sites is deﬁned by combining T0/T0Max¼
z/zmax and Eq. 15. The maximum steady-state isometric
tension were deﬁned solely by SL, as at maximal activation it
was assumed that thin ﬁlament kinetics would play a minimal
role. During SL increases, neither crossbridge kinetics (82) or
the force generated per bound crossbridge (59) are altered.
Gao et al. (89) reported that isometric tension remained the
same before and after skinning, whereas interﬁlament spacing
has been shown to increase in skinned cells compared to intact
cells (97), indicating that interﬁlament spacing does not affect
the length dependence of isometric tension. The higher
maximum tensions at longer SL can potentially be explained
by an increase in the number of crossbridges that can attach at
longer SL due to a decrease in the double overlap between
actin ﬁlaments (76,98–100). The value T0Max is deﬁned by Eq.
15, where l is equal to SL over the resting SL of 2 mm
(46,101,102), Tref is the maximum tension at resting SL, and
b0 is the slope of the lT0Max relationship,
T0Max ¼ Trefð11b0ðl 1ÞÞ: (15)
Limited isometric tension data at varying SL values at
physiological temperatures was available so the parameters
of Eq. 15 were ﬁtted to room temperature results from Table 6.
Numerous isometric tension values were reported for vary-
ing temperatures, magnesium, and ATP concentrations and
preparation types. Fig. 6 plots isometric tensions taken from
Table 6 against SL. The trend line for isometric tension values
recorded under physiological conditions at room temperature
(less four outliers) in Fig. 6 was described by Eq. 15 with
Tref ¼ 56.2 kPa and b0 ¼ 4.9, which is close to the b0
value reported for human myocardium of 4.27 (103). The
four excluded results are indicated by the plus, up-triangle,
asterisk, and square symbols, three from mouse (plus-symbol)
(104), cat (up-triangle) (105), and guinea pig (asterisk) (66),
which may indicate a species difference as the favored animal
in muscle studies is rat. The remaining anomaly (square
symbol) (95) is for intact rat muscle but was excluded due to
the large standard deviation of 24.1 kPa.
Combing T0/T0Max ¼ z/zmax and Eq. 15 gives Eq. 16,
which deﬁnes isometric tension as a function of both SL and
thin ﬁlament kinetics,
T0 ¼ T0Max z
zMax
¼ Trefð11b0ðl 1ÞÞ 
z
zMax
; (16)
where the value z is the fraction of available actin sites
determined by thin ﬁlament kinetics and zmax is the maxi-
mum fraction of available actin sites at a given SL as deﬁned
above by Eq. 14.
Crossbridge kinetics
The fading memory model (11) provides an efﬁcient method
to phenomenologically represent the tension development
associated with crossbridge kinetics using a small number of
parameters. The fading memory model describes the relation-
ship between tension and sarcomere sliding velocity, by
separating tension development into nonlinear static and linear
time-dependent components. The linear time-dependent com-
ponent of the fading memory model is described as the sum of
three exponential processes (Eq. 17), where ai and Ai are the
exponential rate constants and associated weighting coefﬁ-
cients; respectively, l is the strain, g(T,T0) is a static function
of tension and isometric tension, Qi is the value of the i
th
FIGURE 6 Isometric tensions from Table 6 at varying strains, assuming a
resting SL of 2 mm. Solid data points (46,66,71,72,80,89,104,133) represent
measurements taken under physiological conditions deﬁned by [Mg12]
 0.5–1 mM (79,89), ATP  4–5 mM, and SL is 1.9–2.3 mm (7,73,88) at
room temperature 20–22C. The remaining data from Table 6 is plotted as
open circles. Outlying measurements recorded under physiological condi-
tions are marked and correspond to data with large SD. (n) (95) or taken
from a species other than rat, namely mouse (1) (104), cat (:) (105), or
guinea pig (*) (66). Line of best ﬁt to solid circles (d) is T0 ¼ 56.2(1 1
4.9(l1)).
Cardiac Myocyte Relaxation 1707
Biophysical Journal 90(5) 1697–1722
integral, and n is the number of exponential processes. Cell
models are commonly deﬁned in terms of a system of ordinary
differential equations. To adapt the fading memory model to
ﬁt this mold, the right-hand side of Eq. 17 was differentiated
by time to give Eq. 18,
gðT; T0Þ ¼ +
n
i¼1
Ai
Z t
N
e
aiðttÞdl
dt
dt ¼ +
n
i¼1
Qi;
where
Qi ¼ Qi ¼ Ai
Z t
N
e
aiðttÞdl
dt
dt (17)
dQi
dt
¼ Aidl
dt
 aiQi: (18)
Under conditions of steady-state shortening, Eq. 17 yields
the well-known Hill force-velocity relation if g in Eq. 17 is
chosen to be g(T/T0) ¼ (1T/T0)/(T/T01a). Choosing g as a
single function of T/T0 is also consistent with the idea that the
force scales with the number of active crossbridges, reﬂected
in T0. Hill’s force-velocity curve describes the shortening
(positive velocities) but not the lengthening (negative
velocities) of the muscle under a constant load. The velocity
becomes negative when the constant load is greater than the
isometric tension (T. T0). Here, the Hill curve was extended
to model negative velocities. In frog skeletal muscle at 0C,
the magnitude of the negative velocity increases signiﬁcantly
for T . 1.4 T0, but no information was available for more
negative velocities or larger tensions in cardiac muscle (100).
It was assumed that the force v’s velocity relationship for
negative velocities was a reﬂection of the plot for positive
velocities. The original Hill curve for positive velocities is
equal to Eq. 19 for V. 0 and the extended curve for negative
velocities is equal to Eq. 19 for V , 0. In Eq. 19, V is the
sarcomere velocity, V0 is the maximum velocity, T is the
active tension, T0 is the isometric tension, and a is a measure
TABLE 6 Isometric tension
Species Muscle Prep Temp (C) SL (mm) Mg12 (mM) ATP (mM) Tmax (kPa) Ref.
Rat T SP 23 1.65 3 5 46.2 (45)
Rat T SP 23 1.75 3 5 50 (45)
Rat T SP 23 1.85 3 5 63.2 (45)
Mouse P SP RT 1.9 1 5 38.4 (104)
Rat T SP 20 1.9 1 4 44.6 (72)
Rats V SP 15 1.95 1 5 56.8 (46)
Rat T SP 23 1.95 3 5 69.2 (45)
Rat V SP 20 1.98 3 3–5 36.25 (77)
Cat T IP 25 2.0 — — 108 (105)
Rat T SP 20 2 1 4 56.3 (72)
Rats V SP 15 2.05 1 5 60.6 (46)
Rat T SP 23 2.05 3 5 75 (45)
Rat T SP 20 2.1 1 4 68.8 (72)
Rat T SP 20 2.1 1.5 5 37 (80)
Rat T SP 20 2.1 3 5 37.5 (128)
GP T SP 22 2.13 1 6.3 50.6 (66)
Rat T SP 22 2.14 1 6.3 78.9 (66)
Rat T SP 23 2.15 3 5 86.3 (45)
Rats V SP 15 2.15 1 5 65.3 (46)
Rat* T IP 22 2.2 — — 88.5 (133)
Raty T IP 22 2.07–2.2 — — 45.1 (133)
Rat V SP 15 2.2 1 5 39 (88)
Rat T SP 20 2.2 1 4 82.1 (72)
Rat T IP 20–22 2.2 — — 102.4 (95)
Rat T IP 20–22 2.1–2.3 1.2 5 121 (2)
Rat T SP 20 2.2–2.3 0.5 5 90 (89)
Rat T IP 20 2.2–2.3 0.72 — 93 (89)
Rats V SP 15 2.25 1 5 72 (46)
Rat V SP 20 2.35 3 3–5 48.8 (77)
Rat T SP 20 2.3 1 4 92.0 (72)
Mouse P SP RT 2.3 1 5 65.3 (104)
Rats V SP 13 2.29–2.36 1 4 21 (110)
Rat T SP 20 2.4 1 4 96.4 (72)
Cat V IP 30 — — — 18 (55)
Ferret P IP 30 — — — 54.4 (57)
SL is sarcomere length. GP is guinea pig; P is papillary; T is trabeculae; V is ventricle. IP is intact preparation. RT is room temperature. SP is skinned
preparation.
*Controlled SL.
yUncontrolled SL.
1708 Niederer et al.
Biophysical Journal 90(5) 1697–1722
of the curvature of the force-velocity relation (the value a is
equivalent to aT0 in Hill’s original equation). The original
and extended Hill curves are depicted in Fig. 7. The resulting
force-velocity relationship is C1 (slope) continuous, which
provides numerical stability for the computational solution
method as described later.
V 1
aV0
¼
T=T0  1
T=T01 a
T=T0  1
21 a T=T0
V. 0
V, 0
:
8><
>: (19)
Experimental results from constant velocity experiments in
cardiac muscle give values of a as 0.2 (106), 0.5 (1), 0.35
(107), and 0.25 (108). The value a is also dependent on the
exercise regime (a  0.2–0.36) (109) and Pi concentration
(a 0.32–0.36) (110). Considering these values, awas set to
0.35. Other authors have reported values for a ranging
from 0.05 (111) to 0.8 (112) by ﬁtting limited regions of the
force-velocity curve. It has been noted that the Hill equa-
tion does not ﬁt the force-velocity curve for small veloc-
ities (111–113), but the approximation error is relatively
small.
During constant velocity experiments dl/dt¼V, and the
linear component of the fading memory model (right-hand
side of Eq. 17) is equal to
+
n
i¼1
Qi ¼ V +
n
i¼1
Ai
ai
: (20)
Setting the sum of Ai/ai ¼ 1/(aV0) means that the sum of Qi
in Eq. 17 is equal to the right-hand side of Eq. 19. This forms
the relationship between the linear time-dependent and
nonlinear static components of the fading memory model.
The ﬁnal form of the fading memory model was described by
Eq. 21. The extended Hill equation proposed in Eq. 19
ensures that the denominator of Eq. 21 is always greater than
or equal to one, thereby removing the singularity that would
be present if the standard Hill equation were used for both
positive and negative velocities.
T ¼
T0
a+
n
i¼1
Qi1 1
1 +
n
i¼1
Qi
T0
11 ð21 aÞ+
n
i¼1
Qi
11 +
n
i¼1
Qi
+
n
i¼1
Qi, 0
+
n
i¼1
Qi. 0
:
8>>>>>>><
>>>>>>:
(21)
The linear time-dependent component of the fading memory
was described by three exponential processes (11,114) and
requires the deﬁnition of three rate constants and three
amplitude coefﬁcients. Although the effect of temperature on
crossbridge kinetics is signiﬁcant, there was insufﬁcient data
to characterize crossbridge kinetics at physiological temper-
atures and, as such, the parameter set deﬁned here will be for
room temperature, where room temperature was taken as 20–
23C. Sinusoidal analysis provides two rate constants explic-
itly. The four remaining parameters were ﬁtted using the two
deﬁned rate constants and four constraints derived from
experimental results. These constraints are outlined in detail in
the following sections. First, sinusoidal analysis was used to
ﬁnd the minimum stiffness frequency, maximum phase shift
frequency, and the high frequency stiffness. Secondly, the
instantaneous step change required to drop tension to zero was
determined, which required the high frequency stiffness
values from the sinusoidal analysis. Thirdly, the maximum
velocity was deﬁned. The remaining four fading memory
model parameters were then ﬁtted using the four constraints
and the two deﬁned rate constants.
Dynamic stiffness
Sinusoidal analysis provides two of the rate constants
explicitly and the minimum dynamic stiffness frequency,
the maximum phase shift frequency, and the high frequency
stiffness are used to constrain the remaining parameters. The
dynamic stiffness of muscle has been effectively measured
by imposing a small sinusoidal or random noise perturbation
while the muscle is in isometric contraction. The dynamic
stiffness is equal to the tension over the applied length
change and can be described in the frequency domain using
Eq. 22 as proposed by Kawai and Brandt (115) or in the time
domain using the fading memory model (Eq. 17). In Eq. 22,
a , b , c , d are the rate constants and are equal to the
corresponding ai values from Eq. 17 over 2p. A, B, C, and D
are coefﬁcients and equal to the product of the corresponding
Ai values in Eq. 17 and Tref(11a). Using standard nomen-
clature, the negative coefﬁcient is B. In cardiac muscle, B has
the lowest rate and no A process is seen. H is the linear
FIGURE 7 The h data points are calculated from the original Hill
equation with a ¼ 0.35. The solid line indicates adapted Hill equation for
T/T0 . 1.
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passive stiffness, which was not considered in the model of
active contraction described here:
E ¼ H1A if
if 1 a
1B
if
if 1 b
1C
if
if 1 c
1D
if
if 1 d
: (22)
Rossmanith et al. (116) showed that the myosin isoform
present in the preparation played a prominent role in
determining crossbridge kinetics and results from sinusoidal
analysis. Ventricular myosin in mammals appears in three
different forms—i.e., V1, V2, and V3. The predominant forms
are V1 and V3 or a and b, respectively, and their presence is
determined by species and thyroid state. In ferret and rabbit,
V1 is commonly expressed whereas in bovine, humans, and
rats, the V3 type is predominant (116,117). Considering this,
crossbridge kinetic results will be taken preferentially from
rat, human, and bovine preparations.
Sinusoidal perturbation experiments are commonly per-
formed in skinned preparations at full activation (pCa, 4) and
l . 1.1. At full activation, [Ca12]Trpn/[Ca
12]TrpnMax  1 and
z/zMax  1, such that dynamic stiffness (E) is equal to (11):
EjpCa, 4 ¼ T0 b01 ð11 aÞ +
3
k¼1
Ak
if
if 1
ak
2p
0
@
1
A: (23)
Measurements of coefﬁcients and rate constants from sinu-
soidal perturbation experiments are presented in Table 7.
Experiments by Kawai et al. (118), Saeki et al. (114), and
Shibata et al. (119,120) in ferret and rabbit preparations
recorded similar results for V1 myosin isoforms. Results by
Wannenburg et al. (82) in rat myocardium are considerably
different. However, Wannenburg et al. (82) did not report
rates or coefﬁcients with process D ﬁtted, although they
commented that the exclusion of process D had minimal
affect on the rates of processes B and C (a1 and a2). The
converted rate constants b and c (i.e., a1 ¼ 30.78 s1 and
a2 ¼ 132.6 s1) reported by Wannenburg et al. (82) are
comparable to measurements by Ruf et al. (121) and
Campbell et al. (122) for human and rat myocardium,
respectively, and will be used in the model.
Dynamic stiffness data is commonly represented in two
plots—the dynamic modulus plot of the absolute value of
dynamic stiffness against frequency, and the phase shift
against frequency plot. The Nyquist diagram plots phase
against amplitude. The dynamic modulus plot exhibits a
characteristic dip in stiffness at the minimum stiffness
frequency (fmin). The phase shift plot has a single maximum
at the maximum phase shift frequency (Qmax) (115). These
two frequencies provide two points of reference and ensure
that the model produces characteristic plots. Table 8 lists
reported fmin and Qmax values. The value fmin was calculated
using a range of species and temperatures. The value fmin
increases signiﬁcantly with temperature from 1 Hz to 17.25
Hz at 20C and 40C, respectively. There was no deﬁnitive
relationship between myosin isoform and fmin. Rabbit and
ferret have reported fmin values of 0.9–2 Hz at room
temperature. However, the 2 Hz result was recorded with
ATP at 1 mM; excluding this value reduces the range to 0.9–
1.44 Hz. Rat and bovine fmin values range between 1 and 3.2
Hz. The 3.2 Hz reported by Wannenburg et al. (82) was for
partially activated preparations, but Wannenburg et al. (82)
did note that this had a minimal affect on fmin. Rossmanith
et al. (116) reported that V1 and V3 myosin isoforms had an
fmin value of 1.2 Hz and 2.2 Hz, respectively, at 25C. The
value fmin for the model was taken to be 2 Hz. The value
Qmax was reported less often than fmin, and ranges between
2.1 and 8 Hz. It was not known how partial activation affects
Qmax, so the Wannenburg et al. (82) results are not con-
sidered here. The valueQmax for human data is 4.3 Hz (123),
which is comparable to rat (4 Hz) (116), rabbit (4 Hz)
(119,124), and ferret (3.5 Hz) (118) myocardium. Con-
sidering these results, the Qmax for the model was taken
as 4 Hz.
The high-frequency stiffness (HFS) is the stiffness
calculated using the model at pCa , 4 and f/N (Eq. 24).
Experimentally, the HFS is the stiffness at the highest
frequency recorded:
Ejf¼N ¼ Trefb01 Trefð11 aÞ +
n
k¼1
Ak: (24)
The HFS varies signiﬁcantly between authors. Campbell
et al. (122) measured HFS of 0.2–1 M Nm2 at varying
isometric tensions using a low maximum frequency range
TABLE 7 Sinusoidal analysis results
Species Temp (C) pCa Frequency range (Hz) B 2pb C 2pc D 2pd Ref.
Ferret* 20 Ba21y 0.13–135 0.82 7.6 2.09 26 0.90 682 (114)
Ferret 20 4.55 0.13–135 0.72 8.6 1.57 30 0.59 703 (114)
Ferret 20 4.82 0.13–135 0.58 9.9 1.31 23.6 0.42 552 (118)
Rat 23 6.11 0.5–70 1.09 5.97 3.49 47 — — (82)
Rat 23 5.92 0.5–70 2.92 30.78 11.3 133 — — (82)
Humanz 35 5 0.125–100 0.376 25 0.525 70.37 — — (123)
Rat — 4.3 0.1–40 — 33.6 — 190.4 — — (122)
Ferret — — 0.1–40 — 30.41 — 70.56 — — (122)
*These preparations were not skinned.
yBarium contractures.
zHuman patients on numerous medications before the preparations were sampled; patients had an average age of 61.2 years.
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(40 Hz). Wannenburg et al. (82) reported the HFS to be
7.25 M Nm2, again using a low maximum frequency
(70 Hz). The experiments were performed at only partial
activation but recorded viable isometric tensions (87 kPa) at
full activation. Kawai et al. (118) recorded HFS values
of0.9 M Nm2 using a maximum frequency of 135 Hz, but
measured low isometric tension values (18.3 kPa) and
inorganic phosphate concentrations were high (8 mM) in
skinned preparations. Mulieri et al. (123) recorded an HFS of
0.59 M Nm2 in human hearts of patients (average age
61.6) at a maximum frequency of 100 Hz. Saeki et al. (114)
recorded HFS values of 2.50 and 1.44 MNm2 for intact and
skinned preparations, respectively, using a maximum fre-
quency of 135 Hz, but recorded isometric tensions of 49 kPa
and 26 kPa for intact and skinned preparations, respectively,
at Lmax (SL  2.3 mm). The isometric tension values
recorded at full activation in sinusoidal analysis experiments
were characteristically low when compared with static isomet-
ric tension data from Table 6. The large variations in HFS
values meant that these data were not used directly to ﬁt model
parameters but instead were used in the following section to
deﬁne the length step required to drop tension to zero.
Length-step experiments
The step response of the fading memory model is found by
setting l(t) ¼ Dl 3 H(t), where H(t) is the Heaviside step
function, or equivalently dl/dt¼ Dl3 d(t), where d(t) is the
Dirac d-function (11). This gives
T=T0  1
T=T01 a
¼ Dl+
n
i¼1
Aie
ai t: (25)
The length step required to drop tension to zero immediately
after a length change is found by setting t¼ 0 in Eq. 25 and is
equal to Eq. 26:
1
a+
n
i¼1
Ai
¼ Dl: (26)
Instantaneous length steps are not possible in real experi-
ments due to the inertia of testing equipment and muscle. To
overcome this, various experimental methods have been
proposed to elucidate the magnitude of Dl. The value T1 is
the tension after a rapid length step over a ﬁnite duration of
time. For length steps over a ﬁnite duration of time (Dt) with
T1 ¼ 0, there is a linear relationship between Dl and Dt
(100). Hunter et al. (11) exploited this relationship to
determine Dl of 0.5%, as Dt tends to zero using frog and
ferret data (at 0C and 27C, respectively). Backx and ter
Keurs (125) used a similar method to determine a Dl value
of 1.2% in rat muscle (at 5C). An alternate method is to
assume a linear relationship between tension and small
length changes, such that Dl is equal to the ratio of the high
frequency stiffness (HFS) and isometric tension. The HFS
value is not used in isolation, as it varies considerably
between authors as mentioned above. However, the ratio of
HFS to isometric tension varies less and appears to be less
sensitive to myosin isoform, temperature, and muscle
viability than HFS alone. At an SL of 2.1 mm, Wannenburg
et al. (82) measured the ratio of HFS to maximum isometric
tension as 1.2%, which is comparable to HFS measurements
at Lmax (the muscle length, which achieves maximum tension
or SL  2.3 mm) of 1.6–2.0% by Shibata et al. (120), Saeki
et al. (114), and Kawai et al. (118). Considering the results of
both modalities, the value of Dl required to drop tension to
zero in this model will be set to 1.2%.
Maximum velocity experiments
The maximum velocity (V0) of contraction is directly related
to ATPase (111,126), and as such, indicative of crossbridge
kinetics. The maximum velocity occurs under zero load, and
is independent of SL for SL values between 1.9 and 2.2 mm
(111). The fading memory model parameters can be
constrained using Eq. 27 and results from maximum velocity
experiments (11),
1
aV0
¼ +
n
i¼1
Ai
ai
: (27)
Maximum velocity experiments are performed over a range
of temperatures as reported in Table 9, but can be adjusted to
TABLE 8 Maximum phase shift and minimum
dynamic stiffness
Species Temp (C) Qmax (Hz) Fmin (Hz) Comments Ref.
Human 35 4.3 9 (123)
Bovine 40 — 17.25 (127)
Bovine 30 — 5.21 (127)
Bovine 20 — 1 (127)
Bovine 25 7.6 2 5 mM ATP (151)
Rat 25 4 1.8 (116)
Rat 23 8 3.2 pCa 5.92 (82)
Rabbit 24 4.0 1.2 (119)
Rabbit 24 4 1.44 (124)
Ferret 20.2 2.1 1.3 Skinned (114)
Ferret 20.2 1.7 0.9 Intact (114)
Ferret 20 3 2 1 mM ATP (118)
Ferret 20 3.5 2 1 mM ATP (118)
TABLE 9 Maximum muscle velocity at 23C; strain rates
adjusted to 23C using a Q10 value of 4.6
Species
Original temp
(C)
Strain rate
(s1)
Strain rate at
23C (s1) Ref.
Rat 25 13.3 9.8 (149)
Rat 20 6.13 9.6 (111)
Rat 25 12.68 9.34 (111)
Rat 30 23.44 8 (111)
Rat 12 3.45* 18.5 (150)
Cat 25 9.8 7.2 (105)
Rat 22 9.82* 11.4 (84)
*Calculated using ML s1 and SL.
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room temperature using a Q10 of 4.6 (111). A maximum
velocity per sarcomere of 19 mm s1 or a strain rate of
9.5 s1 at room temperature with a resting SL of 2 mm was
set to constrain the parameters in Eq. 23.
Fading memory model parameters
The linear time-dependent component of the fading memory
model has three rate (ai) values and three coefﬁcient (Ai) val-
ues. The frequency values of a1 ¼ 30 s1 and a2 ¼ 130 s1
were set directly to those reported by Wannenburg et al. (82),
as explained above. The remaining four parameters were
calculated by determining the best ﬁt to the four independent
constraints outlined above. These are, the maximum velocity
(Eq. 27), length step experiments (Eq. 26), and fmin (2 Hz) and
Qmax (4 Hz) frequencies. The ﬁtting process was begun by
setting A1 and A2, then calculating A3 using Eq. 26, then a3
was determined using Eq. 27 and ﬁnished using Eq. 23 to
determine fmin and Qmax numerically. Thus, by searching the
parameter space of A1 and A2, the best parameter set for the
four constraints was determined. The resulting values for
the process magnitudes A1, A2, and A3 are 29, 138, and 129,
respectively. The process rates a1, a2, and a3 are 30 s
1,
130 s1, and 625 s1, respectively. The resulting fmin and
Qmax values are 0.9 Hz and 3.75 Hz, respectively. The value
fmin was smaller than the fmin value determined above, from V3
myosin experimental results; however, it was still comparable
with V3 myosin results from Fujita and Kawai (127) (fmin ¼
1 Hz) and V1 myosin results.
MODEL SUMMARY
The complete model is summarized, with the set of param-
eters for (primarily intact rat ventricular) cardiac muscle at
room temperature. The model can be adapted to represent
skinned preparations by changing a0, n, and [Ca
21]50ref to
6 s1, 3.4, and 4.72 mM, respectively.
Parameters
TnC-Ca binding
Equations 2 and 3, where kon ¼ 100 mM1 s1; koffref ¼
200 s1; g ¼ 2.0; and [Ca21]TrpnMax ¼ 70 mM.
Tropomyosin kinetics
Equations 9, 11, and 14, where ar1 ¼ 2 s1; ar2 ¼ 1.75 s1;
Kz ¼ 0.15; nr ¼ 3; b1 ¼ 4.0; a0 ¼ 8 s1; n ¼ 3; zp ¼ 0.85;
and [Ca21]50ref ¼ 1.05 mM.
Tension development
Equations 15, 18, and 21, where Tref ¼ 56.2; b0 ¼ 4.9;
a¼ 0.35; A1¼29; A2¼ 138; A3¼ 129; a1¼ 30 s1; a2¼
130 s1; and a3 ¼ 625 s1.
VALIDATION
The three model components, Ca21 binding to TnC kinetics,
tropomyosin kinetics, and crossbridge kinetics, have been
constructed and parameterized in isolation using a wide
range of preparation types and spatial scales. Comparison
has already been made with experimental data isolating the
function of each component from data using the parameter
set allocated in previous sections. To validate tropomyosin
kinetics, model simulations were compared with caged Ca21
experiments. Crossbridge kinetics were validated using
tension transients after rapid length increases. No obvious
experimental results were available to validate Ca21 binding
to TnC kinetics, but the functional form of Ca21 binding to
TnC (Eq. 2) is a generally accepted model and the tension
dependence of the unbinding rate can be derived from
length-step experiments (Eqs. 4–8). To ensure that when the
ensemble of model components were integrated together the
resulting simulations matched experimental results, model
simulations were compared with SL clamped and SL
unclamped tension traces. Finally, to test that the complete
model was able to characterize RT50, a comparison was
made between simulated RT50 and experimental measure-
ments at increasing muscle length.
Caged calcium activation curves
To verify tropomyosin kinetics, which were deﬁned by
tension relaxation and F-pCa curves, the model was com-
pared with caged calcium release experiment results. In
caged Ca21 experiments nitrophenyl-EGTA is saturated
with Ca21 and then exposed to a ﬂash of light resulting in a
rapid decrease in the Ca21 afﬁnity, causing a rapid increase
in the concentration of free Ca21 (60). This provides a means
of measuring the rate of tension development after a step
change in Ca21. Tropomyosin activation kinetics were
deﬁned using the relaxation kinetics and F-pCa curves. Fig. 8
plots tension traces for guinea-pig caged Ca21 experiments
with SL ¼ 2.18 mm at 23C, taken from Martin et al. (81)
against simulated results using the skinned preparation
parameter set. The Ca21 concentrations after the release of
caged Ca21 was calculated using the ﬁnal relative tensions
and F-pCa curves for skinned preparations described above
with pCa50 ¼ 5.6 and n ¼ 3.
Finite duration length-step changes
For a 1-ms length step of 1% (SL ¼ 2.1 mm) at room
temperature at an inorganic phosphate concentration of
0 mM, the half-relaxation time is 6.0 ms (128), compared
with a half-relaxation time of 6.2 ms predicted by the model
(see Fig. 9). The model also exhibits the characteristic dip
seen when muscle is rapidly stretched, but shows no
evidence of further oscillations observed by Saeki et al.
(129) and Berman et al. (124). The fading memory model
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predicts a signiﬁcant rise in tension after a rapid length
decrease, analogous to the dip in rapid length increase
experiments. The rise predicted by the model after the length
decrease was not seen in rapid length decrease experiments
in cardiac muscle performed by Hancock et al. (130), but has
been observed in both skeletal muscle (131) and cardiac
muscle (132) for very small step sizes (Dl # 0.5%).
Clamped and unclamped sarcomere length
isometric twitches
Inhomogeneous SL shortening in muscle preparations during
an isometric twitch has been shown to cause a signiﬁcant
decrease in developed tension. Janssen and de Tombe (133)
showed that using iterative feedback SL control, the SL could
be held constant, resulting in signiﬁcantly increased devel-
oped tension and a decrease in the amplitude of the [Ca21]i
transient. The tension traces for clamped and unclamped
experiments recorded by Janssen et al. (7) were simulated by
the model using the corresponding experimental [Ca21]i and
SL traces. The ﬂuorescent traces from Janssen and de Tombe
were converted to [Ca21]i values using [Ca
21]i ¼
K9d(RRmin)/(RmaxR), where Kd9 ¼ 2.95 mM, Rmax ¼ 10,
Rmin ¼ 0.2, and R is the ﬂuorescence ratio. Kd9 and Rmax are
taken from Gao et al. (3,89) and Rmin is set such that resting
[Ca21]i is0.1 mM. The calculated [Ca21]i transient and the
experimentally measured SLs are shown in Fig. 10 A. Cubic
splines were ﬁt through the data to produce smooth curves to
input into the model and to compare with simulation results.
The resulting simulated tension traces are compared with
experimental measurements in Fig. 10, B and C. The sim-
ulated results are similar to experimental measurements, al-
though the ﬁnal stages in the unclamped simulations were
notably slower and slightly slower in the clamped simula-
tions. However, RT50 values were well represented by the
model.
Half-relaxation times
As cardiac muscle is stretched at room temperature RT50
during isometric twitch increases (7). Fig. 11 B compares
RT50 for intact rat trabeculae at 22.5C from Janssen et al. (7)
with simulation results from the model. Results from Janssen
and others were recorded at 10 equally spaced lengths be-
tween the resting length and maximum tension length, which
are assumed to correspond to equally spaced SL values be-
tween 1.8 mm and 2.2 mm for simulations. The SL was as-
sumed to remain constant during the isometric twitch,
although SL was not controlled by feedback iterations in the
study of Janssen et al. (7). Thus the [Ca21]i transient is held
ﬁxed for all simulations. Tension transients at each muscle
length are shown in Fig. 11 B. The [Ca21]i transient is
expected to vary at differing SLs, but limited experimental
data is available to characterize this phenomenon.
FIGURE 9 Length steps of 1-ms duration. (A) 1% length-step increase at
23C for SL¼ 2.1 mm and pCa¼ 4. The dashed line is the model prediction;
n is from Kentish (128), (tension scaled to model). (B) 1% length-step
decrease at 23C, for SL ¼ 2.1 mm and pCa ¼ 4.
FIGURE 8 Tension transients after the release of caged Ca21 by
nitrophenyl-EGTA with SL ¼ 2.18 mm and initial pCa ¼ 7. Data points
are from Martin et al. (81) and lines are from model simulations. The;data
points and dashed line, d data points and dash-dot line, n data points and
dotted line, and ¤ data points and solid line had pCa values after the release
of the caged calcium of 5.07, 5.41, 5.56, and 5.69, respectively. The pCa
values were calculated using the ﬁnal relative tensions and the skinned
F-pCa curve deﬁned below with a Hill coefﬁcient of n ¼ 3 and half-
activation value of pCa50 ¼ 5.6.
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RELAXATION FACTORIAL ANALYSIS
The [Ca21]i transient, TnC kinetics, and length dependence
have all being implicated in determining RT50 (134). It is
worth noting that many of the factors are coupled, via tension
dependence, which often results in inconclusive experimen-
tal ﬁndings. To determine the relative importance of the
factors listed in Table 10 on RT50, a full factorial analysis
(135) was performed. A factorial analysis provides a means
to analyze the relative importance of a single factor and
multiple factor interactions on a given output, by approxi-
mating the output as a linear function of all the factors and
determining the coefﬁcients. The magnitude of the coefﬁ-
cients indicates the relative inﬂuence of each factor, includ-
ing multiple factor interactions. Although factorial analysis
uses a linear approximation of a nonlinear output, which is
not ideal, it provides a feasible means to identify signiﬁcant
factors, which can then be analyzed in detail. The output was
deﬁned as the RT50 value for an isometric twitch with a
prescribed [Ca21]i transient and clamped SL ¼ 2.2 mm.
Table 10 summarizes the factor deﬁnitions and values, and
FIGURE 10 (A) Sarcomere lengths from unclamped SL (n) and clamped
SL (d) experiments from Janssen and de Tombe (133). [Ca21]i transients
from unclamped SL (dashed line) and clamped SL (solid line) experiments.
[Ca21]i transients were calculated from ﬂuorescence data from Janssen and
de Tombe (133) and converted to [Ca21]i values using [Ca
21]i ¼
K9d(RRmin)/(RmaxR), where K9d ¼ 2.95 mM, Rmax ¼ 10, Rmin ¼ 0.2
(4,89). (B and C) Clamped and unclamped experiments, respectively;
experimental data are taken from Janssen and de Tombe (133) (solid lines),
and lines are generated by the model (dashed lines).
FIGURE 11 (A) Tension traces for increasing SL from 1.8 mm to 2.2 mm.
(B) RT50, points taken from Janssen et al. (7) at room temperature, with
standard error. Line calculated from model simulations. Arbitrary units
deﬁned by Janssen et al. (7).
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Fig. 12 A shows the relative inﬂuences. During the factorial
analysis, the b0- and g-values used to calculate the con-
centration of calcium bound at half-activation (Eq. 11) were
held constant, since they do not represent any mechanism in
this equation. The factorial analysis identiﬁed the [Ca21]i
transient magnitude and the unbinding rate of Ca21 from
TnC as the two most signiﬁcant factors within the initial
parameter space. A detailed analysis of the parameter space
of the unbinding of Ca21 from TnC and the magnitude of the
[Ca21]i transient on RT50 is shown in Fig. 12 B to illustrate
coupled effects and to determine whether the effect of each
factor is dependent on the parameter space.
DISCUSSION
In this article, we present an improved version of the HMT
model for the active contraction of cardiac muscle and
analyze its behavior, particularly during relaxation. Each
model parameter was determined from a broad range of
experimental results. The model components and the cou-
pling between them were subsequently validated against a
wide range of experimental protocols. After development
and validation, the model was used to quantify the relative
inﬂuence of the tension-dependent unbinding rate of Ca21
from TnC, length-dependent sensitivity, length-dependent
maximum tension, [Ca21]i transient, and the tension-depen-
dent binding of Ca21 to TnC using a factorial analysis. Here
we discuss the validation results, the implications of the
factorial analysis, the sensitivity of the model to speciﬁc
parameters, and the limitations of the model.
Validation
The model has been developed in components using speciﬁc
experimental data, often recorded from experimental proto-
cols speciﬁcally designed to isolate a particular mechanism
or function. Model results have been successfully compared
and validated against a combination of speciﬁc and physi-
ological experimental results and normalized measures of
tension kinetics.
Crossbridge kinetics were validated using rapid length-
step experimental results from Kentish et al. (128) (see Fig.
9). The simulated results matched rapid length increases, but
simulations for length-step decreases exhibited an unex-
pected rise in tension after the length step and no drop in
steady-state tension after the length step was observed. The
rise has been both present (132) and absent (130,136) in cardiac
muscle experiments and has been observed in skeletal
muscle (131). A potential explanation for the absence of the
rise predicted by sinusoidal analysis (115) in quick release
experiments is due to the buckling of the muscle during
release (137). Buckling would not be observed in rapid
stretch experiments and would be more likely to occur with
larger length changes as Hancock et al. (130,136) used a 1%
and 2% length change, compared to 0.05% used by
Rossmanith and Tjokorda (131) and 0.5% used by de Beer
et al. (132). Although no direct comparison can be made
between model simulations and results by de Beer et al., who
did not include the duration of the length step or provide a
scale for tension. The rate constants used in the fading
memory part of the HMT model are independent of [Ca21]i
but the thin ﬁlament kinetics are not. So the effect of Ca21 on
the rate of tension redevelopment depends on [Ca21]i, which
TABLE 10 Factors and variable descriptions and values for
factorial experiment
Factor # Variable High value (1) Low value ()
1 Unbinding rate of Ca21
from TnC
koff ¼ 220 s1 koff ¼ 180 s1
2 Length-dependent sensitivity b0 ¼ 5.4 b0 ¼ 4.41
3 Length-dependent maximum
tension
b1 ¼ 1.3 b1 ¼ 1.06
4 [Ca21]i transient magnitude 110% 90%
5 Tension-dependent binding
of Ca21 to TnC
g ¼ 2.2 g ¼ 1.8
FIGURE 12 (A) Relative effects of individual and two-factor interactions
for prescribed [Ca21]i transient and SL ¼ 2.2 mm. Single-digit factors
correspond to the variables listed in Table 10 and two-digit factors indicate
the coupled effect of the variables from Table 10 corresponding to each
digit; for example, 45 corresponds to the coupled affect of the [Ca21]i
transient and the tension dependence of Ca21 binding to TnC . (B) The RT50
calculated using the model with the [Ca21]i and the unbinding rate of Ca
21
from TnC varying between 50 and 150% of their original values.
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is not observed by Hancock et al. (130,136), but is seen by
Backer et al. (138) and Wolff et al. (139). The second
difference between simulations and experimental results was
the absence of a decrease in steady-state tension after the
length step. Signiﬁcant decreases have been observed in
ferret cardiac (130) and frog skeletal (140) muscle experi-
mentally. In a critical review of this phenomenon, Rassier
and Herzog (141) attributed the change in isometric tension
to nonuniformity of SLs and stress-induced inhibition of
crossbridge attachment after length steps. These observa-
tions are not accounted for by the model, due to the scarcity
of speciﬁc data for cardiac tissue.
Ca21 activation kinetics were deﬁned using tension
relaxation kinetics and F-pCa curves. Tension transients
after the release of increasing concentrations of free Ca21
were used to validate tropomyosin kinetics (see Fig. 8). The
tension trace after the release of caged Ca21 were closely
followed by the simulated tension transients. The model was
capable of representing a Ca21-dependent monoexponential
rise in tension, while at the same time having a biphasic
relaxation, as seen experimentally (61).
The complete model was compared with isometric twitch
data from Janssen and de Tombe (133) with clamped and
unclamped SL values (see Fig. 10). The model was able to
replicate the tension traces, although the ﬁnal phase of
relaxation predicted by the model for both the clamped and
unclamped twitch were slower than observed experimen-
tally. In both cases, the use of experimental data recorded at
15C to determine the tropomyosin relaxation parameters
may have contributed to the delay in relaxation. In the
unclamped case, the approximation of the force-velocity
curve may also have caused reduced relaxation rates, as
discussed below. The oscillations in the late phase of
relaxation in the unclamped case is due to the imposed SL,
which results in a forced SL velocity and the uncoupling of
the feedback between velocity and tension. If the active
contraction model was coupled to a passive mechanics
model then the feedback between the passive and active
mechanics would result in a smoother relaxation phase.
The model also quantitatively matches the increase in
RT50 with increasing SL values, as seen experimentally by
Janssen et al. (7) (see Fig. 11). An earlier study by Janssen
and Hunter (4) using SL control to maintain the SL during
contractions found lower RT50 values than both the model
predictions and experimental results from Janssen et al. (7).
However, only one data set is available from Janssen and
Hunter (4) with n ¼ 1, and no corresponding Ca21 transient
is provided. As such, a direct comparison is not possible.
Janssen and Hunter (4) also reported that as SL decreased,
the rate that tension fell from 25 to 10% of maximum tension
increased. This phenomenon is not explicitly captured by the
model, which predicts an increase in relaxation rate with SL
within this range, although the model does predict an in-
crease in relaxation rates for decreasing SL for larger SL
values as tension drops from 35 to 25%.
The ability of the model to replicate speciﬁc tension
twitches and RT50 trends supports the validity of the hypo-
thesized model structure and parameter set.
Relaxation
The factorial analysis performed above highlighted the un-
binding rate of Ca21 from TnC and the [Ca21]i transient
magnitude as the principle factors determining RT50. The
tension-dependent binding of Ca21 to TnC and the length-
dependent Ca21 sensitivity played a secondary role and max-
imum tension and two-factor interactions did not signiﬁcantly
affect RT50 values in the examined parameter space.
The effect of an increase in the unbinding rate of Ca21 from
TnC on the relaxation has been studied experimentally by
phosphorylating troponin I using protein kinase A, causing
30% increase in the unbinding rate of Ca21 from TnC
(6,92). The increase in unbinding rate has been shown to
cause a decrease in RT50 in intact preparations (142) and both
an increase (6,61) and no effect (64) in the rate of relaxation in
skinned preparations, using light-activated Ca21 chelators.
The factorial analysis identiﬁed the unbinding of Ca21 from
TnC as a signiﬁcant determinant of relaxation.
The effect of SL on RT50 was separated into the length
dependence of tension and calcium sensitivity. The SL tension
dependence had a minimal affect on RT50, whereas the length-
dependent calcium sensitivity had a signiﬁcant affect on RT50.
Experimental results fromJanssen andHunter (3) found tension
and not SL correlated with relaxation times, suggesting that
either the tension dependence of Ca21 binding to TnC or that
bound crossbridges inhibit tropomyosin returning to the off-
state, are responsible for the increase in relaxation timewith SL.
Kentish andWrzosek (143) and Janssen et al. (7) also recorded
a decrease inRT50 at shorterSLs, but the effect ofSLwould also
be confounded by changes in the tension transient, which
potentially causes changes in the binding of Ca21 to TnC and
thus has an effect on the relaxation time. The Ca21 sensitivity
affects both maximum tension and RT50, coinciding with the
observations of Janssen and Hunter (4). However, since no
deﬁnitive mechanism currently exists to explain the length-
dependent Ca21 sensitivity as discussed above, the dependence
of RT50 on Ca
21 sensitivity cannot be determined.
Model simulations show that RT50 increases with the
[Ca21]i transient magnitude, when the [Ca
21]i transient and
the unbinding rate of Ca21 from TnC are close to their
reference values. Increasing the extracellular Ca21 concen-
tration, which increases the [Ca21]i transient magnitude, has
been observed to cause an increase (3,4), a decrease (3), and
no change (144) in relaxation rates. Fig. 12 B shows the
combined effects of the unbinding rate and the [Ca21]i
transient magnitude on RT50. The [Ca
21]i transient causes
both a decrease and an increase in RT50, as seen by Gao et al.
(3), depending on the [Ca21]i transient magnitude and the
unbinding rate of Ca21 from TnC.
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The unbinding of Ca21 from TnC and the [Ca21]i transient
are the most signiﬁcant factors in determining RT50. The
coupled effects of TnC and the [Ca21]i transient on RT50 were
determined using a broader range of parameter values (see Fig.
12 B) and showed that the minimum RT50 was a function of
both the [Ca21]i transient and the unbinding rate of Ca
21 from
TnC, such that the effect of the [Ca21]i transient and the
unbinding rate of Ca21 from TnC could both either increase or
decrease RT50 depending on the reference value of each
parameter. For example, for the base [Ca21]i transient, in-
creasing the unbinding rate of Ca21 from TnC increase or
decreases RT50 when the unbinding rate is more or less than
130%, respectively.
Sarcomere velocity and crossbridges inhibiting the move-
ment of tropomyosin to the off-state were not included in this
study. To attain realistic tension twitches, where the muscle
contracts, requires the use of physiological force boundary
conditions. To account for the affect of SL velocity under this
protocol requires the deﬁnition of a passive stiffness model,
which is beyond the scope of this article. Crossbridge
inhibition is not accounted for explicitly, and could poten-
tially affect a number of tropomyosin kinetics parameters
(ar2, nr, Kz). Crossbridge inhibition may, in part, account for
the signiﬁcant effect of the [Ca21]i transient on RT50, and
may need to be considered at a later date.
Sensitivity
The model described above contains numerous parameters
deﬁned using a range of experimental data. To fully assess
the validity of the model, the sensitivity of model results to
individual parameters needed to be determined. The rele-
vance and quality of data used to determine sensitive param-
eters was then assessed to attain a sense of the accuracy and
degree of conﬁdence in the model.
The sensitivity of the model to speciﬁc parameters was
determined by calculating the Jacobean of the root-mean-
square change in tension (for the unclamped sarcomere
tension trace), with respect to the parameter set. The tension
transient was most sensitive to CaTrpn50ref and Kz, and
insensitive to changes in either the crossbridge kinetics or
Ca21 binding to TnC.
CaTrpn50ref was determined using the Ca
21 bound to TnC
model and free Ca21 (Eq. 12) at half-activation values from
skinned and intact preparations. The CaTrpn50ref value for
skinned preparations was calculated from 17 experiments at
different SL values. However, adjusting CaTrpn50ref to
account for the affects of skinning used only three measures
at one SL and the effect of skinning on the length dependence
of half-activation was assumed to be negligible. To conﬁrm
the validity of the value and length dependence of
CaTrpn50ref, further experiments on intact preparations are
required as, although many factors have been qualitatively
implicated in determining the effects of skinning on the half-
activation, there is currently no established relationship
between skinned and intact half-activation values.
The value Kz was deﬁned by ﬁtting Eq. 14 to tension
transients after step changes in Ca21. The value Kz was
determined by ﬁtting a nonlinear equation to characteristic
tension traces and our conﬁdence in its value is therefore less
than parameters directly reported in the literature, which are
taken from numerous samples. The experiments used to
determine Kz were also performed at 12–15C in air and the
tension reached during the experiment was commonly 50%
of the maximum tension. Further experiments at more
physiological temperatures over a broader range of tensions
would assist in better deﬁning Kz to increase the validity of
the model and conclusions drawn from it.
Limitations
This model aims to account for a wide range of experimental
results and mechanisms. Although the model is capable of
representing a large proportion of available experimental
data, it is an approximation, and as such, has limitations,
which must be taken into consideration when considering
results. In the model, certain components have a limited repre-
sentation of experimental results and some potential mech-
anisms were not included. These include: the length- and
tension-dependence of Ca21 binding to TnC, the changes in
half-activation due to skinning, relying on the approximation
of the Hill equation, the models’ approximation of the F-pCa
curve, and inhomogeneous sarcomere shortening in relaxa-
tion, which are discussed below.
The tension-dependent binding of Ca21 to TnC is only
valid for the physiological range of SL values and fails to
predict the concentration of bound Ca21 during contraction
at low free Ca21 concentrations. The model is designed to
operate within the physiological range of SL values for intact
preparations between 1.8, SL, 2.3 mm. Extensions beyond
2.3 mm do not occur under physiological conditions in vivo.
Simulating isolated experimental protocols where SL .
2.3mm, the model will predict that more than one Ca21 ion
binding to each available site II in TnC as koff becomes less
than zero, which is not reported. For simulations where SL ,
2.3 mm, koff. 0 if T, gTref for all tension values, resulting in
the condition that g . 1 1 b0(l1), which is true for the
proposed parameter set. Combining the active tension model
described here with a model for passive tension (11) would
constrain SLs to be below 2.3 mm and so avoid this problem.
The fraction of Ca21 bound to TnC at lower SL values
reported by Fuchs et al. (44) is not accurately represented by
the model. However, there is an ampliﬁcation of experimental
noise inherent in the method used here to extrapolate the
fraction of Ca21 bound to site II from the experimental results
(discussed in the Tension-Dependent Ca21 unbinding rate
from Troponin C) which increases as bound Ca21 decreases.
This impedes the accurate measurement Ca21 bound to site II
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using the total quantity of Ca21 bound to all TnC sites as the
sole source of experimental data.
The half-activation of cardiac muscle is often reduced
after skinning. Here the half-activation is scaled to match
intact preparation data, but the half-activation length depen-
dence (b0) is not deﬁned for intact preparations and as such it
is assumed to be independent of skinning. Further experi-
ments on the length dependence of Ca21 activation would
help to elucidate which parts of the contractile machinery are
affected by the skinning process.
Crossbridge kinetics after a length perturbation was de-
scribed by the fading memory model. The static nonlinear
component of the fadingmemorymodel is describedby theHill
equation. The Hill equation exhibits two problems. Firstly, the
Hill curve has been shown to be insufﬁcient to represent
experimental force-velocity results for small velocities (111).
Secondly, the force-velocity relationship for negativevelocities
is not described by the Hill curve, which is therefore extended
here to cover both positive and negative velocities. Further
experimental evidence is required to appropriately characterize
the force velocity curve for negative velocities.
The steady-state F-pCa curve (see Fig. 5) is steeper for
midlevel [Ca21] than low and high [Ca21], which is a problem
endemic in mean-ﬁeld-averaged models as noted by Rice and
de Tombe (76). A potential solution to this problem is the
explicit representation of the regulatory proteins as proposed
by Rice and de Tombe, but this method is not currently
computationally feasible for the simulations performed here.
Recent tension transients after a rapid drop in local Ca21
recorded by Stehele et al. (5,145) and Belus et al. (146) did
not contain the fast and slow processes seen in light-activated
Ca21 chelator experiments. Stehele et al. and Belus et al.
found an initial linear relaxation phase followed by expo-
nential relaxation similar to that seen in skeletal muscle
(100). The initial linear phase is most pronounced in the
absence of Pi. However, the linear phase is muted when Pi is
at physiological concentrations of 2 mM (146), and therefore
is not considered in this model.
Our results reveal the importance of the [Ca21]i transient
and unbinding of Ca21 from TnC as the signiﬁcant factors
affecting RT50. The tension dependence of Ca
21 binding to
TnC and length-dependent Ca21 have a lesser affect and
length-dependent maximum tension appears to have a min-
imal inﬂuence on RT50. A sensitivity analysis of the tension
transient found simulation results to be most sensitive to
tropomyosin kinetics, but this does not detract from the
principal ﬁnding that the [Ca21]i transient and the unbinding
of Ca21 from TnC are the signiﬁcant factors in determining
the relaxation of cardiac muscle, based on the current under-
standing of cardiac contraction.
Applications
In this study, amodelwas developed to rationalize awide range
of experimental data and to rationalize the mechanisms that
control relaxation. The efﬁcient computational form of the
model allows it to be applied to both single and multicellular
simulations. For example, the active mechanics model de-
scribed here has been incorporated into continuum models of
tissue to determine large deformationmechanics solutions and,
ultimately, coupled electromechanics interactions within the
heart. This will ultimately provide the ability to link cellular
mechanisms in health and pathological states to whole organ
function and, in doing so, further the goals of integrative
physiology efforts such as the IUPS physiome project (147).
SUMMARY
A wide range of experimental results has been surveyed to
provide a parameter set for the HMT model, which coincides
with the majority of reported experimental results. The model
illustrates the importance of the coupled effects of the Ca21
transient and the unbinding rate of Ca21 from TnC on the rate
of relaxation and the limited effects of SL on RT50. The model
tension traces are most sensitive to the bound Ca21 at half-
activation in intact preparations and Kz. Further experiments
characterizing the length dependence of half-activation in
intact preparations and relaxation kinetics performed under
more physiological conditions over a wider range of tensions
would assist in improving the conﬁdence in model results. The
model is designed to be applied in multiscale tissue and organ
simulations, which is necessary to gain further understanding
of the effects of tissue and passive mechanics on relaxation.
Data from experimental studies used to validate the model
are listed. A full description of the model is available using
the CellML ontology at www.cellml.org/examples/maths_
pdf/NHS_maths.pdf (148).
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